March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Sharper: Trump's First 100 Days
Commentary
Donald Trump takes office in a complex and volatile global environment. Rising tensions with China, the continued war in Ukraine, and instability in the Middle East all pose s...
By Charles Horn
-
Build a High-Low Mix to Enhance America’s Warfighting Edge and Deter China
Commentary
The Trump administration can take immediate actions to improve U.S. military capability, capacity, and warfighting to deter China and reverse negative trends in military power...
By Stacie Pettyjohn, Carlton Haelig, Becca Wasser & Josh Wallin
-
Defense & Aerospace Air Power Podcast: Doctor, Doctor, Give Me the News:
Podcast
On this podcast, they continue looking ahead to airpower issues in the coming year with Dr. Stacie Pettyjohn, Director of the Defense Program at the Center for a New American ...
By Stacie Pettyjohn
-
The United States Can’t Afford to Not Harden Its Air Bases
Commentary
The United States can continue to largely ignore this menace and watch as risk levels increase, or it can face the reality and shape its forces and infrastructure to prevail....
By Tom Shugart & Timothy A. Walton
